Thanks, Mr. Chair.
Hello to staff, colleagues, and witnesses.
My questions will be focused on Innovative Medicines Canada.
It was maybe three or four months ago now that I spoke with one of your team members, Bobby Sutherland, and learned that a number of your clients from start-ups to large companies were involved in researching COVID-19, and specifically vaccine exploration.
Can you give me an idea of how many of these vaccine development projects are still under way, and are there any hopeful candidates? Can you give us a sense of where we are with what you know at this time?